Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Rifaximin Tablets 550 mg (Rifagut)
Connect with this vendor - Learn about this product

Rifaximin Tablets 550 mg (Rifagut)

Each film coated tablet contains Rifaximin 550 mg
for the treatment of patients (≥12 years of age) with traveler’s diarrhea caused by noninvasive strains of Escherichia coli; for the reduction of overt hepatic encephalopathy & irritable bowel syndrome with diarrhea (IBS-D) treatment in adult men and women.

  • Presentation: Tablet
  • Strength:  550mg  
  • Pack Size: 100 Tablets
  • Pack Insert: Yes
  • Marketing Authorization Holder: Sun Pharma Laboratories
  • Manufacturing License: JK/01/07-08/124